Cullen/Frost Bankers’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.1K Buy
508
+58
+13% +$2.34K ﹤0.01% 1048
2026
Q1
$15K Buy
450
+60
+15% +$2.51K ﹤0.01% 1048
2025
Q4
$17.7K Buy
390
+39
+11% +$1.43K ﹤0.01% 1026
2025
Q3
$10.7K Buy
351
+5
+1% +$154 ﹤0.01% 1064
2025
Q2
$10.2K Buy
346
+256
+284% +$7.66K ﹤0.01% 1030
2025
Q1
$3.15K Buy
90
+24
+36% +$952 ﹤0.01% 1108
2024
Q4
$2.94K Buy
+66
New +$2.96K ﹤0.01% 1089
2023
Q2
Sell
-109
Closed -$6.39K 1237
2023
Q1
$6.39K Buy
+109
New +$6.01K ﹤0.01% 999
2022
Q3
Sell
-175
Closed -$20K 1180
2022
Q2
$20K Hold
175
﹤0.01% 839
2022
Q1
$23K Hold
175
﹤0.01% 859
2021
Q4
$32K Sell
175
-375
-68% -$65K ﹤0.01% 838
2021
Q3
$82K Hold
550
﹤0.01% 655
2021
Q2
$83K Buy
550
+375
+214% +$52.2K ﹤0.01% 667
2021
Q1
$23K Hold
175
﹤0.01% 840
2020
Q4
$21K Sell
175
-55
-24% -$5.39K ﹤0.01% 839
2020
Q3
$17K Hold
230
﹤0.01% 849
2020
Q2
$16K Buy
+230
New +$15.7K ﹤0.01% 843

Other funds holding OMCL

Cullen/Frost Bankers's OMCL Position: Q2 2026 in Review

Cullen/Frost Bankers increased its Omnicell (OMCL) stake by 13% in Q2 2026, buying an estimated $2.34K and bringing the position to 508 shares worth $21.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1048.

Cullen/Frost Bankers first reported a position in OMCL in Q2 2020 and has held it in 17 quarters since. The position peaked at $83K in Q2 2021. 306 funds tracked by Wall St. Rank hold OMCL as of Q2 2026.

  • Cullen/Frost Bankers held 508 shares of Omnicell worth $21.1K as of Q2 2026.
  • Cullen/Frost Bankers bought 58 Omnicell shares in Q2 2026, an estimated $2.34K.
  • Omnicell made up ﹤0.01% of Cullen/Frost Bankers's portfolio in Q2 2026, its #1048 holding.
  • Cullen/Frost Bankers first reported a position in Omnicell in Q2 2020 and has held it in 17 quarters since.
  • Cullen/Frost Bankers's Omnicell position peaked at $83K in Q2 2021.
  • 306 funds tracked by Wall St. Rank held Omnicell as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.